Ganoderma lucidum suppresses endothelial cell cytotoxicity and proteinuria in persistent proteinuric focal segmental glomerulosclerosis (FSGS) nephrosis

A persistent proteinuria is commonly observed in nephrotic patient with focal segmental glomerulosclerosis (FSGS) under treatment with prednisolone ± cyclophosphamide or with vasodilators (ACEI + AII receptor antagonist, calcium channel blocker and antiplatelet agent). Fourteen such patients with pe...

Full description

Saved in:
Bibliographic Details
Published inClinical hemorheology and microcirculation Vol. 31; no. 4; pp. 267 - 272
Main Authors Futrakul, Narisa, Panichakul, Tasanee, Butthep, Punnee, Futrakul, Prasit, Jetanalin, Pim, Patumraj, Suthiluk, Siriviriyakul, Prasong
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.01.2004
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A persistent proteinuria is commonly observed in nephrotic patient with focal segmental glomerulosclerosis (FSGS) under treatment with prednisolone ± cyclophosphamide or with vasodilators (ACEI + AII receptor antagonist, calcium channel blocker and antiplatelet agent). Fourteen such patients with persistent proteinuria were subject to be treated with Ganoderma lucidum. Initial study revealed an enhanced endothelial cell cytotoxicity induced by patient's serum, and an altered immunocirculatory balance with predominant proinflammatory cytokine TNF alpha activity in the presence of defective anti‐inflammatory cytokine interleukin‐10. Treatment with Ganoderma lucidum suppressed endothelial cell cytotoxicity, restored immunocirculatory balance and successfully suppressed proteinuria in all of these 14 patients.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1386-0291
1875-8622
DOI:10.3233/CHM-2004-ch725